Taiyuan
Taiyuan
Taiyuan, Shangxi, China4 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Clinical Trial on the Efficacy and Safety of TQB6411 for Injection | Advanced Lung Cancer | Recruiting | Phase 1 / Phase 2 | 2026-09-08 | NCT07367529 | |
| DZD8586 in Patients With Relapsed or Refractory CLL/SLL (TAI-SHAN8) | B-cell chronic lymphocytic leukemia, Chronic Disease, Disease Attributes, Hemic and Lymphatic Diseases, Leukemia, B-Cell, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, chronic lymphocytic leukemia/small lymphocytic lymphoma, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, neoplasm | Recruiting | Phase 2 | 2026-06-02 | NCT06539182 | |
| Clinical Studies for the Treatment of Advanced Solid Tumors | Advanced Solid Tumor | Recruiting | Phase 1 / Phase 2 | 2025-12-18 | NCT06825494 | |
| CD30 CAR-T in the Treatment of CD30 Positive Relapsed/Refractory Lymphoma | B-cell neoplasm, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm | Recruiting | Not applicable | 2025-02-27 | NCT06850285 |